Jeff Yass’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Jeff Yass's UNCY Position: Q3 2026 in Review
Jeff Yass reduced its Unicycive Therapeutics (UNCY) stake by 17% in Q3 2026, selling an estimated $141K and leaving 132,830 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #9140.
Jeff Yass first reported a position in UNCY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.31M in Q1 2026. 93 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Jeff Yass held 132,830 shares of Unicycive Therapeutics worth $624K as of Q3 2026.
- Jeff Yass sold 27,209 Unicycive Therapeutics shares in Q3 2026, an estimated $141K.
- Unicycive Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9140 holding.
- Jeff Yass first reported a position in Unicycive Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Jeff Yass's Unicycive Therapeutics position peaked at $1.31M in Q1 2026.
- 93 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.